Strategic Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
12,157
+1,363
| +13% | +$145K | 0.21% | 96 |
|
|
2025
Q1 | $1.34M | Sell |
10,794
-548
| -5% | -$68K | 0.27% | 92 |
|
|
2024
Q4 | $1.4M | Sell |
11,342
-5,858
| -34% | -$721K | 0.26% | 83 |
|
|
2024
Q3 | $1.92M | Sell |
17,200
-175
| -1% | -$19.5K | 0.38% | 70 |
|
|
2024
Q2 | $1.85M | Buy |
17,375
+323
| +2% | +$34.5K | 0.39% | 75 |
|
|
2024
Q1 | $2.05M | Sell |
17,052
-437
| -2% | -$52.6K | 0.44% | 75 |
|
|
2023
Q4 | $2.15M | Sell |
17,489
-12,056
| -41% | -$1.48M | 0.49% | 70 |
|
|
2023
Q3 | $3.82M | Buy |
+29,545
| New | +$3.82M | 0.64% | 61 |
|
|
2021
Q2 | – | Sell |
-36,466
| Closed | -$5.99M | – | 165 |
|
|
2021
Q1 | $5.99M | Sell |
36,466
-515
| -1% | -$84.7K | 1.08% | 27 |
|
|
2020
Q4 | $6.1M | Sell |
36,981
-12,092
| -25% | -$2M | 1.08% | 26 |
|
|
2020
Q3 | $7M | Buy |
49,073
+3,871
| +9% | +$552K | 1.32% | 18 |
|
|
2020
Q2 | $4.99M | Buy |
45,202
+6,707
| +17% | +$740K | 1.07% | 26 |
|
|
2020
Q1 | $3.84M | Buy |
38,495
+9,071
| +31% | +$905K | 0.99% | 29 |
|
|
2019
Q4 | $4.39M | Buy |
29,424
+427
| +1% | +$63.7K | 0.91% | 32 |
|
|
2019
Q3 | $3.72M | Sell |
28,997
-2,472
| -8% | -$317K | 0.84% | 38 |
|
|
2019
Q2 | $4.49M | Sell |
31,469
-420
| -1% | -$59.9K | 0.96% | 30 |
|
|
2019
Q1 | $4.56M | Buy |
+31,889
| New | +$4.56M | 0.96% | 30 |
|